2 ms·
Moderna and Merck shares soar on mRNA cancer vaccine
- ChrisArchitect 2mo agoRelated: Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma https://news.ycombinator.com/item?id=49361395 https://news.ycombinator.com/item?id=49361395